Experienced in Transient Ischemic Attack (TIA)

Lauren M. Sanders

St Vincent's Hospital Melbourne, 
Melbourne, VIC, AU 
Experienced in Transient Ischemic Attack (TIA)
St Vincent's Hospital Melbourne, 
Melbourne, VIC, AU 
OverviewLocationsClinical Research

Overview

Lauren Sanders practices in Melbourne, Australia. Ms. Sanders is rated as an Experienced expert by MediFind in the treatment of Transient Ischemic Attack (TIA). Her top areas of expertise are Amaurosis Fugax, Stroke, Transient Ischemic Attack (TIA), Thrombectomy, and Carotid Artery Surgery.

Her clinical research consists of co-authoring 34 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 6 articles in the study of Transient Ischemic Attack (TIA).

Gender
Female

Locations

St Vincent's Hospital Melbourne, Melbourne, VIC, Australia
Other Locations
Level 5, Clayton Road, Clayton, VIC 3169, Australia
Level 5, E Block 246, Clayton Road, Clayton, VIC 3168, Australia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

STOP-MSU: Stopping Haemorrhage With Tranexamic Acid for Hyperacute Onset Presentation Including Mobile Stroke Units. A Phase II Randomised, Placebo-controlled, Investigator-driven Trial of Tranexamic Acid Within 2 Hours of Intracerebral Haemorrhage
STOP-MSU: Stopping Haemorrhage With Tranexamic Acid for Hyperacute Onset Presentation Including Mobile Stroke Units. A Phase II Randomised, Placebo-controlled, Investigator-driven Trial of Tranexamic Acid Within 2 Hours of Intracerebral Haemorrhage
Enrollment Status: Completed
Publish Date: September 28, 2023
Intervention Type: Drug
Study Drug: Tranexamic Acid
Study Phase: Phase 2
A Multicentre, Randomised Controlled Trial of Exenatide Versus Standard Care in Acute Ischemic Stroke (TEXAIS)
A Multicentre, Randomised Controlled Trial of Exenatide Versus Standard Care in Acute Ischemic Stroke (TEXAIS)
Enrollment Status: Unknown
Publish Date: September 14, 2021
Intervention Type: Drug
Study Drug: Exenatide
Study Phase: Phase 2
View 1 Less Clinical Trial

34 Total Publications

"When the Word Is Too Big, It's Just Too Hard": Stroke Survivors' Perspectives About Health Literacy and Delivery of Health Information.
"When the Word Is Too Big, It's Just Too Hard": Stroke Survivors' Perspectives About Health Literacy and Delivery of Health Information.
Journal: Healthcare (Basel, Switzerland)
Published: January 26, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Sanders's expertise for a condition
ConditionClose
        View All 13 Experienced Conditions
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile